Carlisle Companies Inc (CSL) 99.16 $CSL Carlisle

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Carlisle Companies Inc (CSL) 99.16 $CSL

Carlisle Acquires Micro-Coax
BusinessWire - Fri Jun 10, 2:35PM CDT
Carlisle Companies Incorporated (NYSE:CSL) today announced the acquisition of Micro-Coax, Inc., a leading global supplier of high-performance, high frequency coaxial wire and cable, and cable assemblies for mission-critical RF/microwave applications for defense, satellite, test and measurement and other industrial customers.
CSL: 99.16 (-0.64)

Crane's Long-Term Prospects Solid, Runs Near-Term Risks
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 6:54AM CDT
We issued an updated research report on Crane Co. (CR) on Jun 7.
MMM: 167.13 (-1.43), CR: 57.82 (-0.96), CSL: 99.16 (-0.64)

Downgrade Alert for Carlisle Cos (CSL)
Comtex SmarTrend(R) - Fri Jun 03, 3:20AM CDT
Carlisle Cos (NYSE:CSL) was downgraded from Buy to Neutral at Northcoast today. The stock closed yesterday at $101.00 on volume of 948,000 shares, above average daily volume of 425,000. In the past 52 weeks, Carlisle Cos share prices have been bracketed by a low of $75.17 and a high of $105.79 and closed yesterday at $101.00, 34% above that low price. The 200-day and 50-day moving averages have moved 0.05% lower and 1.06% higher over the past week, respectively.
CSL: 99.16 (-0.64)

Look for Shares of Carlisle Cos to Potentially Rebound after Yesterday's 3.39% Sell Off
Comtex SmarTrend(R) - Thu Jun 02, 1:08PM CDT
Carlisle Cos (NYSE:CSL) traded in a range yesterday that spanned from a low of $100.92 to a high of $103.97. Yesterday, the shares fell 3.4%, which took the trading range below the 3-day low of $102.65 on volume of 510,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CSL: 99.16 (-0.64)

Carlisle Cos Up 24.8% Since SmarTrend Uptrend Call (CSL)
Comtex SmarTrend(R) - Wed Jun 01, 1:02AM CDT
SmarTrend identified an Uptrend for Carlisle Cos (NYSE:CSL) on February 1st, 2016 at $83.20. In approximately 4 months, Carlisle Cos has returned 24.79% as of today's recent price of $103.82.
CSL: 99.16 (-0.64)

Carlisle Companies to Present at KeyBanc's Conference in Boston June 1
BusinessWire - Tue May 31, 7:59AM CDT
D. Christian "Chris" Koch, President and Chief Executive Officer of Carlisle Companies Incorporated (NYSE:CSL), will be conducting a General Session at KeyBanc's Conference at the InterContinental Hotel in Boston, MA at 1:05 p.m. (Eastern) Wednesday, June 1, 2016. PowerPoint slides of the presentation are available on the Investor Relations section of Carlisle's website at www.carlisle.com.
CSL: 99.16 (-0.64)

Uptrend Call Working As Carlisle Cos Stock Rises 24.2% (CSL)
Comtex SmarTrend(R) - Tue May 24, 1:47PM CDT
SmarTrend identified an Uptrend for Carlisle Cos (NYSE:CSL) on February 1st, 2016 at $83.20. In approximately 4 months, Carlisle Cos has returned 24.21% as of today's recent price of $103.33.
CSL: 99.16 (-0.64)

Seqirus receives FDA approval for FLUCELVAX QUADRIVALENT(TM) (Influenza Vaccine) for people four years of age and older
PR Newswire - Mon May 23, 7:50PM CDT
Seqirus announced today that the US Food and Drug Administration (FDA) has approved FLUCELVAX QUADRIVALENT(TM) (Influenza Vaccine), the first four-strain, cell culture-derived, inactivated seasonal influenza vaccine for people aged four years and older.1,2 FLUCELVAX QUADRIVALENT helps protect against the two influenza A viruses and two B viruses recommended by the World Health Organization (WHO) and the FDA for the current influenza season.2
CSL: 99.16 (-0.64), NVS: 77.33 (-1.61)

Carlisle Appoints Kevin P. Zdimal Vice President of Business Development; Carlisle Appoints Titus B. Ball Vice President and Chief Accounting Officer
BusinessWire - Fri May 20, 8:00AM CDT
Carlisle Companies Incorporated (NYSE:CSL) announced today the appointment of Kevin P. Zdimal to the position of Vice President of Business Development. Mr. Zdimal joined Carlisle in 1995 and has worked in a number of leadership roles at Carlisle's corporate office and Carlisle's Interconnect Technologies division.
CSL: 99.16 (-0.64)

22.3% Return Seen to Date on SmarTrend Carlisle Cos Call (CSL)
Comtex SmarTrend(R) - Tue May 17, 1:25AM CDT
SmarTrend identified an Uptrend for Carlisle Cos (NYSE:CSL) on February 1st, 2016 at $83.20. In approximately 4 months, Carlisle Cos has returned 22.30% as of today's recent price of $101.75.
CSL: 99.16 (-0.64)

GE to Buy HRSG Unit to Boost Power Business, Drive Top Line
Zacks Equity Research - Zacks Investment Research - Wed May 11, 9:38AM CDT
GE Power, a division of General Electric Company (GE), recently inked an agreement to acquire Doosan Engineering & Construction's Heat Recovery Steam Generator (HRSG) business.
GE: 29.83 (-0.21), HON: 115.13 (-1.55), CSL: 99.16 (-0.64), CLC: 59.69 (-0.80)

Otis to Build New R&D Center & Test Tower, Unveils SkyBuild
Zacks Equity Research - Zacks Investment Research - Tue May 10, 3:34PM CDT
Otis China, a unit of United Technologies Corp. (UTX), recently announced that it will be building a new elevator test tower in Shanghai.Otis also introduced its new SkyBuild self-climbing construction elevator as part of the SkyRise family.
HON: 115.13 (-1.55), UTX: 101.21 (-0.79), CSL: 99.16 (-0.64), CLC: 59.69 (-0.80)

Carlisle Companies to Present at Oppenheimer Conference in New York City May 10
BusinessWire - Mon May 09, 8:00AM CDT
D. Christian "Chris" Koch, President and Chief Executive Officer of Carlisle Companies Incorporated (NYSE:CSL), will be presenting at Oppenheimer's 11th Annual Industrial Growth Conference at the Westin Grand Central Hotel in New York City, at 1:05 p.m. (Eastern) Tuesday, May 10, 2016. PowerPoint slides of the presentation are available on the Investor Relations section of Carlisle's website at www.carlisle.com.
CSL: 99.16 (-0.64)

ITT Corp. (ITT) Q1 Earnings Meet, Revenues Top, Stock Down
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:21AM CDT
ITT Corp. (ITT) posted adjusted earnings of 59 cents per share in the first quarter of 2016, in line with the Zacks Consensus Estimate but down 9.2% from the year-ago tally of 65 cents.
HON: 115.13 (-1.55), ITT: 34.42 (-0.77), CSL: 99.16 (-0.64), CLC: 59.69 (-0.80)

GE Closes Sale of Aussie & Kiwi Commercial Lending Assets
Supriyo Bose - Zacks Investment Research - Wed May 04, 2:41PM CDT
General Electric Company (GE) has recently completed the divesture of GE Capital's Commercial Lending and Leasing assets in Australia and New Zealand.
GE: 29.83 (-0.21), CR: 57.82 (-0.96), CSL: 99.16 (-0.64), CLC: 59.69 (-0.80)

United Technologies Affiliate Expands Foothold in Foley
Zacks Equity Research - Zacks Investment Research - Wed May 04, 10:32AM CDT
UTC Aerospace Systems, a division of United Technologies Corp. (UTX), recently announced the expansion of its existing facility in Foley, AL.
HON: 115.13 (-1.55), UTX: 101.21 (-0.79), CSL: 99.16 (-0.64), CLC: 59.69 (-0.80)

Carlisle Companies Declares Regular Quarterly Dividend
BusinessWire - Wed May 04, 8:35AM CDT
The Board of Directors of Carlisle Companies Incorporated (NYSE:CSL) has declared a regular quarterly dividend of $0.30 per share, payable on June 1, 2016 to shareholders of record at the close of business on May 18, 2016.
CSL: 99.16 (-0.64)

Is Carlisle Companies (CSL) a Great Growth Stock?
Zacks Equity Research - Zacks Investment Research - Tue May 03, 8:15AM CDT
Solid earnings growth prospects, coupled with impressive Zacks Rank has made Carlisle Companies (CSL) an interesting choice for the investors.
CSL: 99.16 (-0.64)

Shares of CSL Up 24.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Apr 29, 1:29AM CDT
SmarTrend identified an Uptrend for Carlisle Cos (NYSE:CSL) on February 1st, 2016 at $83.20. In approximately 3 months, Carlisle Cos has returned 24.08% as of today's recent price of $103.23.
CSL: 99.16 (-0.64)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Vimi Wellness and Goodan: A Fusion of Women's Healing

Updated Category News Views 22

Crossing Continents for Women's Healing When Chelsey Goodan, an American expert in adolescent education, made her way to Hangzhou, China, it wasn't just another stop on her world tour. No, this was her first venture into China, rallying with Zhang Xinyuan, the brains behind Vimi Wellness. For those not in the know, Vimi's been pioneering women's intimate health and...

Continue Reading
UK Government Seeks Reliable Job Data Amid Survey Issues

Updated Category News Views 66

UK Government Faces Job Data Reliability Crisis The UK government has recently identified a pressing challenge in acquiring dependable jobs data essential for effective economic policy-making. This issue has arisen due to flaws in the Labor Force Survey conducted by the Office for National Statistics (ONS), which is the main instrument used to gauge the UK job market. The...

Continue Reading
HII Boosts Shareholder Confidence With New Dividend Announcement

Updated Category News Views 205

HII Announces Quarterly Cash Dividend HII (NYSE: HII) has made a significant declaration that is likely to resonate well with its shareholders. Recently, the company's Board of Directors confirmed a quarterly cash dividend of $1.35 per share to be distributed on June 13, 2025. This move underscores HII's ongoing commitment to its investors, as it rewards those holding...

Continue Reading
ZTE's Global Summit 2025: Shaping a Smarter Future in Milan

Updated Category News Views 201

ZTE's Global Summit 2025: Shaping a Smarter Future in Milan Milan recently hosted a significant event as ZTE Corporation, a renowned leader in integrated information and communication technology solutions, gathered industry leaders from around the world. Under the theme "Expanding Intelligence, Creating Possibilities," the event focused on the crucial aspects of AI-driven...

Continue Reading
Dr. Stelios Papadopoulos Joins Ovid Therapeutics' Board

Updated Category News Views 111

Dr. Stelios Papadopoulos Appointed to Ovid Therapeutics Board Ovid Therapeutics Inc. (NASDAQ: OVID), an innovative biopharmaceutical company, has made headlines with the announcement of Dr. Stelios Papadopoulos joining its Board of Directors. Known for his remarkable contributions to biotechnology, Dr. Papadopoulos brings with him a wealth of experience that promises to...

Continue Reading